Newsroom
Pure-DEL has received CHF 150,000 from Venture Kick to target the undruggable
18.11.2025
ETH spin-off Pure-DEL has received CHF 150,000 from Venture Kick to advance its technology for tackling some of the most challengi ... more
CHF 40,000 for AI property management, targeted cancer drugs, and 3D engineering tools
17.11.2025
Bewy, Biodelphis Therapeutics, and nureo were selected in the second stage of Venture Kick’s support program. Their projects inclu ... more
GlioCART receives CHF 150,000 from Venture Kick to fight the most aggressive form of brain cancer
17.11.2025
GlioCART has obtained CHF 150,000 from Venture Kick to develop a new type of cell therapy – the first CAR-T cell therapy – designe ... more
Newsletter Archive
Press releases
Press review
Forgis erhält CHF 150'000 von Venture Kick
Media contacts
For media enquiries, please email our communications team. If you have a general question about Venture Kick please visit our about us page.
Learn more about Venture Kick or download the latest annual report for detailed information.
